Overall Score

Growth

Revenue base remains small, with revenue per share at 1.07, leaving room for scaling if commercialization improves.

Research and development intensity is very high at 2.38x revenue, which supports pipeline optionality but also signals heavy ongoing investment needs.

Profitability

TTM margins remain deeply negative, with EBIT margin at -205.0% and net profit margin at -197.7%.

Returns on capital are still negative, including ROIC at -18.1% and ROE at -24.3%, indicating the business is not yet generating profitable growth.

Financial Health

Liquidity is very strong, with a current ratio of 18.5x and cash ratio of 2.56x.

The balance sheet appears conservatively financed, with debt-to-equity at 0 and cash per share of 13.52 versus book value per share of 13.00.

Valuation

Valuation remains extremely demanding, with EV/Sales at 97.7x and price-to-sales at 99.4x.

Negative earnings and cash flow keep earnings yield and free cash flow yield negative, limiting support for the current market value.

Momentum

No fresh news was provided this month, so there is no new catalyst to improve or weaken the momentum view.

The stock still looks dependent on future execution rather than current operating momentum.